Clinical Trial Update: A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1 [Phase 2]

View source ↗

Summary

This entry notes the completion of a randomized, placebo-controlled Phase 2 trial of lovastatin in children with Neurofibromatosis Type 1, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Neurofibromatosis Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2018-03-12